RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CIRILLO P
Collezione AOU Novara

Items : 8

Antithrombotic Therapy in High Bleeding Risk, Part II: Noncardiac Percutaneous Interventions. in JACC. Cardiovascular interventions / JACC Cardiovasc Interv. 2024 Oct 28;17(20):2325-2336. doi: 10.1016/j.jcin.2024.09.011.

2024
AOU Novara

Galli M; Gragnano F; Berteotti M; Marcucci R; Gargiulo G; Calabrò P; Terracciano F; Andreotti F; Patti G; De Caterina R; Capodanno D; Valgimigli M; Mehran R; Perrone Filardi P; Cirillo P; Angiolillo DJ;

Antithrombotic Therapy in High Bleeding Risk, Part I: Percutaneous Cardiac Interventions. in JACC. Cardiovascular interventions / JACC Cardiovasc Interv. 2024 Oct 14;17(19):2197-2215. doi: 10.1016/j.jcin.2024.08.022.

2024
AOU Novara

Low platelet count at admission has an adverse impact on outcome in patients with acute coronary syndromes: from the START Antiplatelet registry. in Scientific reports / Sci Rep. 2024 Jun 24;14(1):14516. doi: 10.1038/s41598-024-64113-5.

2024
AOU Novara

Gresele P; Guglielmini G; Del Pinto M; Calabrò P; Pignatelli P; Patti G; Pengo V; Antonucci E; Cirillo P; Fierro T; Palareti G; Marcucci R;

Monitoring antiplatelet therapy: where are we now? in Journal of cardiovascular medicine (Hagerstown, Md.) / J Cardiovasc Med (Hagerstown). 2023 Apr 1;24(Suppl 1):e24-e35. doi: 10.2459/JCM.0000000000001406. Ep

2023
AOU Novara

Marcucci R; Berteotti M; Gragnano F; Galli M; Cavallari I; Renda G; Capranzano P; Santilli F; Capodanno D; Angiolillo DJ; Cirillo P; Calabrò P; Patti G; De Caterina R;

Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome. in Internal and emergency medicine / Intern Emerg Med. 2021 Sep;16(6):1583-1591. doi: 10.1007/s11739-021-02640-z. Epub 2021 Feb 22.

2021
AOU Novara

Cavallari I; Maddaloni E; Gragnano F; Patti G; Antonucci E; Calabrò P; Cirillo P; Gresele P; Palareti G; Pengo V; Pignatelli P; Marcucci R;

Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry. in International journal of cardiology / Int J Cardiol. 2021 Mar 15;327:176-182. doi: 10.1016/j.ijcard.2020.10.079. Epub 2020 Nov 3.

2021
AOU Novara

Fierro T; Antonucci E; Cirillo P; Pengo V; Patti G; Pignatelli P; Calabrò P; Del Pinto M; Guglielmini G; Gresele P; Palareti G; Marcucci R;

Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry. in Internal and emergency medicine / Intern Emerg Med. 2021 Mar;16(2):379-387. doi: 10.1007/s11739-020-02404-1. Epub 2020 Jun 15.

2021
AOU Novara

Sasso FC; Gaudio C; Pelliccia F; Palareti G; Cirillo P; Pignatelli P; Antonucci E; Cavallari I; Patti G; Ielasi A; Pafundi PC; Cesaro A; Calabrò P; Moscarella E; Gragnano F; Pengo V; Gresele P; Marcucci R;

Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry. in International journal of cardiology / Int J Cardiol. 2021 Dec 15;345:7-13. doi: 10.1016/j.ijcard.2021.10.138. Epub 2021 Oct 23.

2021
AOU Novara

Cesaro A; Gragnano F; Calabrò P; Moscarella E; Santelli F; Fimiani F; Patti G; Cavallari I; Antonucci E; Cirillo P; Pignatelli P; Palareti G; Pelliccia F; Bossone E; Pengo V; Gresele P; Marcucci R;